Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Victoria Vandzhura"'
Autor:
Victoria Vandzhura, Pierre Maison-Blanche, Yongbin Ni, Mirko De Melis, Paul Dorian, Benoit Tyl, Stefan H. Hohnloser, Prashanthan Sanders, A. John Camm, Peter R. Kowey
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 5:21-28
Aims Antiarrhythmic drugs (AADs) for the treatment of atrial fibrillation (AF) are associated with limited efficacy and adverse effects. Inhibition of the atrial current IKur, absent from the ventricle, is expected to be antiarrhythmic, without adver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7f51813cd4eab89a0a3443fb68ef142
https://doi.org/10.1093/ehjcvp/pvy022
https://doi.org/10.1093/ehjcvp/pvy022
Autor:
Dominik Lautsch, Nilesh J. Samani, Guenter Breithardt, Dan Atar, Matthias Endres, Peter G. M. Mol, Hakima Hannachi, Maria Borentain, Anders Svensson, Andrew Zalewski, Paulus Kirchhof, Chantal Le Floch, Uwe Fraass, Salim Janmohamed, Jackson Neville Colin, Huseyin Naci, Martin J Landray, Jan G.P. Tijssen, Joerg Kreuzer, Tim Friede, Cathrine Thorstensen, Martin van Eickels, Victoria Vandzhura
Publikováno v:
European Heart Journal, 37(9), 747-754. Oxford University Press
European heart journal, 37(9), 747-754. Oxford University Press
European heart journal, 37(9), 747-754. Oxford University Press
Aims Cardiovascular disease is the most common cause of mortality and morbidity in the world, but the pharmaceutical industry's willingness to invest in this field has declined because of the many challenges involved with bringing new cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7c5ce985a71c2d6cfaf378ccd4f0b4
http://ora.ox.ac.uk/objects/uuid:712f56d2-028b-443d-9506-1533ae3fc41b
http://ora.ox.ac.uk/objects/uuid:712f56d2-028b-443d-9506-1533ae3fc41b